Cancer Keys: Faecal Calprotectin

Potential pitfall:

Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It is therefore not good at defining either the site or the cause of inflammation.

Helpful hint:

The NICE DG11 guidance recommends faecal calprotectin testing as an option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD), or irritable bowel syndrome (IBS), in adults with recent onset lower gastrointestinal symptoms for whom specialist assessment is being considered, if:

    • cancer is not suspected, having considered the risk factors (for example, age) described in the NICE guideline on suspected cancer and
    • appropriate quality assurance processes and locally agreed care pathways are in place for the testing.

Cancer Keys are brought to you by GatewayC.

Download this Cancer Key here

Read the NICE NG12 guidance here

Access GatewayC’s Faecal Immunochemical Test (FIT) course here

LinkedIn Twitter | Facebook

Latest from the Blog

Could you spot bowel cancer in younger patients?

Could you spot bowel cancer in younger patients?

Monday 12th April 2021 Younger patients often do not fit the criteria for a suspected cancer pathway referral. However, every year over 2,500 younger people are diagnosed with bowel cancer in the UK. According to Bowel Cancer UK, this is only around 6% of those...

read more

Related Posts

Cancer Keys: Oesophageal cancer and dysphagia

Cancer Keys: Oesophageal cancer and dysphagia

Potential pitfall: Dysphagia is the most common presenting symptom of oesophageal cancer. It should be considered alongside a number of other symptoms when contemplating an upper gastrointestinal cancer referral. Helpful hint: NICE NG12 guidelines recommend offering...

read more